Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Taiwan Advance Bio-Pharmaceutical, Inc. (4186) Income Statement

Taiwan Advance Bio-Pharmaceutical, Inc. Income Statement

Last quarter (Q2 2026), Taiwan Advance Bio-Pharmaceutical, Inc.'s total revenue was NT$153.10M, an increase of 0.95% from the same quarter last year. In Q2, Taiwan Advance Bio-Pharmaceutical, Inc.'s net income was NT$-16.18M. See Taiwan Advance Bio-Pharmaceutical, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 364.79MNT$ 354.17MNT$ 315.98MNT$ 318.24MNT$ 243.36M
NT$ 227.30MNT$ 243.97MNT$ 198.46MNT$ 192.58MNT$ 124.79M
NT$ 198.30MNT$ 199.13MNT$ 194.19MNT$ 184.18MNT$ 227.59M
Depreciation and AmortizationNT$ 19.67MNT$ 20.62MNT$ 25.90MNT$ 28.18MNT$ 30.39M
NT$ 48.67MNT$ 50.65MNT$ 21.81MNT$ 38.00MNT$ -76.69M
NT$ 29.00MNT$ 44.84MNT$ 4.27MNT$ 7.61MNT$ -102.82M
NT$ -1.85MNT$ -22.23MNT$ -15.66MNT$ -3.93MNT$ -11.62M
NT$ 27.16MNT$ 22.60MNT$ -11.39MNT$ 3.69MNT$ -114.44M
NT$ 28.05MNT$ 22.88MNT$ -10.68MNT$ 3.17MNT$ -118.53M
Per Share Metrics
Basic EPSNT$ 0.31NT$ 0.25NT$ -0.12NT$ 0.04NT$ -1.32
Diluted EPSNT$ 0.31NT$ 0.25NT$ -0.12NT$ 0.04NT$ -1.32
Weighted Average Shares Outstanding90.00M90.00M89.02M90.00M90.00M
Weighted Average Shares Outstanding (Diluted)90.00M90.00M90.00M90.00M90.00M

Currency in TWD

Taiwan Advance Bio-Pharmaceutical, Inc. Earnings and Revenue History

-250M0250M500M-100 %-50 %0 %50 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin